Nonsustained ventricular tachycardia: Where do we stand?

European Heart Journal

Volumn 25, Issue 13, 2004, Pages 1093-1099

  Katritsis, Demosthenes G ^a   Camm, A John ^a  

^a NONE

Author keywords

Nonsustained; Ventricular tachycardia

Indexed keywords

ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; BRUGADA SYNDROME; CLINICAL TRIAL; DEFIBRILLATOR; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; HUMANS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 3042537823     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.03.022     Document Type: Review

References (83)

1. Buxton A.E., Duc J., Berger E.E., et al. Nonsustained ventricular tachycardia. Cardiol. Clin. 18:2000;327-336
2. Kinder C., Tamburro P., Kopp D., et al. Thee clinical significance of nonsustained ventricular tachycardia: current perspectives. PACE. 17:1994;637-664
3. Camm A.J., Katritsis D. Risk stratification of patients with ventricular arrhythmias. Zipes D.P., Jalife J. Clinical electrophysiology. From cell to bedside. 3rd ed. 2000;808-827 Saunders
4. Elizari M.V., Martinez J.M., Belziti C., et al. Mortality following early administration of amiodarone in acute myocardial infarction: results of the GEMICA trial. Circulation. 94(suppl 1):1996;90
5. Cairns J.A., Connolly S.J., Gent M., et al. Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Circulation. 84:1991;550-557
6. Julian D.G., Camm A.J., Frangin J., et al. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet. 349:1997;662-663
7. Senges J.C., Becker R., Schreiner K.D., et al. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial. Pacing Clin. Electrophysiol. 25:2002;183-190
8. Farmer D.M., Swygman C.A., Wang P.J., et al. Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators). Am. J. Cardiol. 91:2003;606-609
9. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341:1999;1882-1890
10. Pires L.A., Lehmann M.H., Buxton A.E., et al. The Multicenter Unsustained Tachycardia Trial Investigators. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications. J. Am. Coll. Cardiol. 38:2001;1156-1162
11. Pires L.A., Hafley G.E., Lee K.L., et al. Multicenter Unsustained Tachycardia Trial Investigators. Prognostic significance of nonsustained ventricular tachycardia after coronary bypass surgery in patients with left ventricular dysfunction. J. Cardiovasc. Electrophysiol. 13:2002;757-763
12. Mittal S., Lomnitz D.J., Mirchandani S., et al. Prognostic significance of nonsustained ventricular tachycardia after revascularization. J. Cardiovasc. Electrophysiol. 13:2002;342-346
13. Russo A.M., Hafley G.E., Lee K.L., et al. Multicenter Unsustained Tachycardia Trial Investigators. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation. 108:2003;67-72
14. Cullen K., Stenhouse N.S., Wearne K.L., et al. Electrocardiograms and 13 year cardiovascular mortality in Busselton study. Br. Heart J. 47:1982;209-212
15. Bikkina M., Larson M.G., Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham heart study. Ann. Int. Med. 117:1992;990-996
16. Kennedy H.L., Whitlock J.A., Sprague M.K., et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N. Engl. J. Med. 312:1985;193-198
17. Montague T.J., McPherson D.D., MacKenzie B.R., et al. Frequent ventricular ectopic activity without underlying cardiac disease: Analysis of 45 subjects. Am. J. Cardiol. 52:1983;980-984
18. Ritchie A.H., Kerr C.R., Qi A., et al. Nonsustained ventricular tachycardia arising from the right ventricular outflow tract. Am. J. Cardiol. 64:1989;594-598
19. Katritsis D., Gill J., Camm A.J. Repetitive monomorphic ventricular tachycardia. Zipes D.P., Jalife J. Clinical electrophysiology. From cell to bedside. 1995;900-906 Saunders
20. Carlson M.D., White R.D., Trohman R.G., et al. Right ventricular outflow tract ventricular tachycardia: detection of previously unrecognized anatomic abnormalities using cine magnetic resonance imaging. J. Am. Coll. Cardiol. 24:1994;720-727
21. Chimenti C., Calabrese F., Thiene G., et al. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation. 104:2001;168-173
22. Ouyang F., Cappato R., Ernst S., et al. Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the Purkinje network. Circulation. 105:2002;462-469
23. O'Donnell D., Cox D., Bourke J., et al. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur. Heart J. 24:2003;801-810
24. Fleg J., Lakatta E. Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers. Am. J. Cardiol. 54:1984;762-764
25. Bruce R.A., DeRouen T.A., Hossack K.F. Value of maximal exercise tests in risk assessment of primary coronary heart disease events in healthy men. Five years' experience of the Seattle heart watch study. Am. J. Cardiol. 46(3):1980;371-378
26. Drory Y., Pines A., Fisman E.Z., et al. Persistence of arrhythmia exercise response in healthy young men. Am. J. Cardiol. 66(15):1990;1092-1094
27. Nair C.K., Aronow W.S., Sketch M.H., et al. Diagnostic and prognostic significance of exercise-induced premature ventricular complexes in men and women: a four year follow-up. J. Am. Coll. Cardiol. 1:1983;1201-1206
28. Jouven X., Zureik M., Desnos M., et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N. Engl. J. Med. 343:2000;826-833
29. Udall J.A., Ellestad M.H. Predictive implications of ventricular premature contractions associated with treadmill stress testing. Circulation. 56(6):1977;985-989
30. Vlay S.C. Catecholamine-sensitive ventricular tachycardia. Am. Heart J. 114:1987;455-461
31. Leenhardt A., Lucet V., Denjoy I., et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 91:1995;1512-1519
32. Cheema A.N., Sheu K., Parker M., et al. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: tachycardia characteristics and their prognostic implications. Circulation. 98:1998;2030-2036
33. Bigger J.T., Fleiss J.L., Rolnitzky L.M. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am. J. Cardiol. 58:1986;1151-1160
34. Burkart F., Pfisterer M., Kiowski W., et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol. 16:1990;1711-1718
35. Maggioni AP, Zuanetti G, Franzosi MG, et al. on behalf of GISSI-2 Investigators. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI results. Circulation 1993;87:312-322
36. The Multicenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-336
37. Mukharji J., Rude R.E., Poole W.K., et al. Risk factors for sudden death after acute myocardial infarction: Two-year follow-up. Am. J. Cardiol. 54:1984;31-36
38. Caruso A.C., Marcus F.I., Hahn E.A., et al. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic study versus electromagnetic monitoring. Circulation. 96:1997;1888-1892
39. Hohnloser S.H., Klingenheben T., Zabel M., et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J. Am. Coll. Cardiol. 33:1999;1895-1902
40. La Rovere MT, Pinna GD, Hohnloser SH, et al. ATRAMI Investigators. Autonomic tone and reflexes after myocardial infarction. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001;103:2072-2077
41. La Rovere M.T., Bigger J.T. Jr., Marcus F.I., et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 351:1998;478-484
42. Abildstrom SZ, Jensen BT, Agner E, et al. BEAT Study Group. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 2003;14:168-173
43. Huikuri H.V., Tapanainen J.M., Lindgren K., et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J. Am. Coll. Cardiol. 42:2003;652-658
44. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-412
45. The Cardiac Arrhythmia Suppression Trial-II Investigators. Effect of antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial-II. N Engl J Med 1992;327:227-233
46. Singh S.N., Fletcher R.D., Fisher S.G., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N. Engl. J. Med. 333:1995;77-82
47. Ruberman W., Weinblatt E., Golberg J.D., et al. Ventricular premature beats and mortality after myocardial infarction. N. Engl. J. Med. 297:1977;750-757
48. Califf R.M., McKinnis R.A., Burks J., et al. Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. Am. J. Cardiol. 50:1982;23-31
49. Moss A.J. Dead is dead, but can we identify patients at increased risk for sudden cardiac death? J. Am. Coll. Cardiol. 42:2003;659-660
50. Buxton AE, Lee KL, Hafley GE, et al. MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002;106:2466-2472
51. Kowey P.R., Taylor J.E., Marinchak R.A., et al. Does programmed stimulation really help in the evaluation of patients with nonsustained ventricular tachycardia? Results of a meta-analysis. Am. Heart J. 123:1992;481-485
52. Wilber D.J., Olshansky B., Moran J.F., et al. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation. 82:1990;350-358
53. Moss A.J., Zareba W., Hall W.J., et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic use of an implanted defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346:2002;877-883
54. Monahan K.M., Hadjis T., Hallett N., et al. Relation of induced to spontaneous ventricular tachycardia from analysis of stored far-field implantable defibrillator electrograms. Am. J. Cardiol. 83:1999;349-353
55. Wyse D.G., Talajic M., Hafley G.E., et al. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J. Am. Coll. Cardiol. 38:2001;344-351
56. Maron B.J., Savage D.D., Wolfson J.K., et al. Prognostic significance of 24 hour ambulatory ECG monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am. J. Cardiol. 48:1981;252-257
57. Monserrat L., Elliott P.M., Gimeno J.R., et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J. Am. Coll. Cardiol. 42:2003;873-879
58. Tamburro P., Wilber D. Sudden death in idiopathic dilated cardiomyopathy. Am. Heart J. 124:1992;1035-1045
59. Doval H., Nul D., Grancelli H., et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1:1994;493-498
60. Doval H.C., Nul D.R., Grancelli H.O., et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation. 94:1996;3198-3203
61. Antzelevitch C., Brugada P., Brugada J., et al. Brugada syndrome: 1992-2002: a historical perspective. J. Am. Coll. Cardiol. 41:2003;1665-1671
62. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation. 105:2002;1342-1347
63. Moss A.J., Zareba W., Hall W.J., et al. Effectiveness and limitations of beta-blocker therapy in congenital LQTS. Circulation. 101:2000;616-623
64. Katritsis D., Camm A.J. Role of invasive electrophysiology testing in the evaluation and management of idiopathic ventricular fibrillation. Cardiac EP Review. 1:1998;452-456
65. Klein H., Auricchio A., Reek S., et al. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am. J. Cardiol. 83(5B):1999;91D-97D
66. Kadish A., Quigg R., Schaechter A., et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin. Electrophysiol. 23:2000;338-343
67. Singh S.N., Fisher S.G., Carson P.E., et al. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J. Am. Coll. Cardiol. 32:1998;942-947
68. Sugrue D.D., Rodeheffer R.J., Codd M.B., et al. The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann. Intern. Med. 117:1992;117-123
69. Strickberger SA, Hummel JD, Bartlett TG, et al. AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712
70. Grimm W., Hoffmann J.J., Muller H.H., et al. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J. Am. Coll. Cardiol. 39:2002;780-787
71. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 105:2002;1453-1458
72. Grimm W., Christ M., Bach J., et al. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation. 108:2003;2883-2891
73. McKenna W.J., Behr E.R. Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death. Heart. 87:2002;169-176
74. Maron B.J. Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Curr. Cardiol. Rep. 2:2000;522-528
75. Maron B.J., Shen W.K., Link M.S., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 342:2000;365-373
76. Brugada J., Brugada R., Antzelevitch C., et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V(1) to V(3). Circulation. 105:2002;73-78
77. Klein R.C. Ventricular arrhythmias in aortic valve disease: analysis of 102 patients. Am. J. Cardiol. 53:1984;1079-1083
78. Martinez-Rubio A., Schwammenthal Y., Schwammenthal E., et al. Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias and syncope. Results of programmed ventricular stimulation and long-term follow-up. Circulation. 96:1997;500-508
79. Garson A., Gilette P.C., Gutgesell H.P. Stress-induced ventricular arrhythmias after tetralogy of Fallot repair. Am. J. Cardiol. 46:1980;1006
80. Deanfield J.E., McKenna W.J., Hallidie-Smith K.A. Detection of late arrhythmias and conduction disturbance after correction of tetralogy of Fallot. Br. Heart J. 44:1980;248
81. Cameron J.S., Myerburg R.J., Wong S.S., et al. Electrophysiological consequences of chronic experimentally induced left ventricular pressure overload. J. Am. Coll. Cardiol. 2:1983;481-487
82. McLenaghan J.M., Henderson E., Morris K.I., et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N. Engl. J. Med. 317:1987;787-792
83. Papademetriou V., Price M., Notargiacomo A., et al. Effect of diuretic therapy on ventricular arrhythmias in hypertensive patients with and without left ventricular hypertrophy. Am. Heart J. 110:1985;595-599